Lingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 183-186

  Yayan, Josef ^a  

^a Diabetes Center Vinzentius Hospital   (Germany)

Author keywords

Alteplase; Angioedema; Ischemic stroke; Macroglossia

Indexed keywords

ALTEPLASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN E; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INCIDENCE; LINGUAL ANGIOEDEMA; MACROGLOSSIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT;

EID: 84877120624     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S29200     Document Type: Article

References (10)

1. Micieli G, Marcheselli S, Tosi PA. Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag. 2009;5:397-409.
2. Hill MD, Barber PA, Takahashi J, et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ. 2000;162:1281-1284.
3. Ottomeyer C, Sick C, Hennerici MG, Szabo K. Orolingual angioedema under systemic thrombolysis with rt-PA: an underestimated side effect. Nervenarzt. 2009;80:459-463.
4. Tsang TS, Califf RM, Stebbins AL, et al. Incidence and impact of on outcome streptokinase allergy in the GUSTO-1-trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. Am J Cardiol. 1997;79:1232-1235.
5. White HD, Cross DB, William BF, et al. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. Br Heart J. 1990;64:177-181.
6. Hill MD, Lye T, Moss H, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology. 2003;60:1525-1527.
7. Cugno M, Cicardi M, Colucci M, Bisiani G, Merlini PA, Spinola A, et al. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Thromb Haemost. 1996;76:234-238.
8. Rudolf J, Grond M, Prince WS, Schmülling S, Heiss WD. Evidence of anaphylaxy after alteplase infusion. Stroke. 1999;30:1142-1143.
9. Krmpotic KR, CM. Anaphylactoid reaction to recombinant tissue plasminogen activator. Eur J Emerg Med. Febuary 2007;14: 60-61.
10. Okada Y, Shibazaki K, Sakai K, Kobayashi K, Iguchi Y, Kimura K. Orolingual angioedema as complication after rt-PA in stroke patient treated with ACE inhibitor. Rinsho Shinkeigaku. 2008;48: 278-280.